Creative Options is state-approved to provide ADT, CLS, and Respite through the Michelle P. Waiver and Supports for Community Living programs. We look forward to the opportunity to work with individuals to help them reach their personal goals. Contact us for more information.
New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer: Molecular Therapy - Oncolytics
mCRPC Patients Receiving 225Ac-PSMA-617 Therapy in the Post–Androgen Deprivation Therapy Setting: Response to Treatment and Survival Analysis
Creative Options, Inc.
Insights for Innovation - Online Course – IDEO U
Apollo Global Management Strikes $6.93 Billion Deal to Buy ADT - WSJ
Creative Economy - Shaping the Future of Design
Cancers, Free Full-Text
ADT Command Review
ADT and Google announce availability of first integrated smart home security system for DIY customers - ADT
ChatGPT for SAP developments – threat or an opportunity?